Circulating calcification inhibitors are associated with arterial damage in pediatric patients with primary hypertension

BACKGROUND: Circulating calcification inhibitors: fetuin A (FA) and osteoprotegerin (OPG) together with soluble ligand of receptor activator of nuclear factor kappa-B (sRANKL) have been linked to vascular calcifications and arterial damage. This study aimed to evaluate relationships between FA, OPG,...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzypczyk, Piotr, Stelmaszczyk-Emmel, Anna, Szyszka, Michał, Ofiara, Anna, Pańczyk-Tomaszewska, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260424/
https://www.ncbi.nlm.nih.gov/pubmed/33604725
http://dx.doi.org/10.1007/s00467-021-04957-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260424/
https://www.ncbi.nlm.nih.gov/pubmed/33604725
http://dx.doi.org/10.1007/s00467-021-04957-5

Ejemplares similares